PIACENTINI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 5.832
EU - Europa 2.496
AS - Asia 584
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 8.933
Nazione #
US - Stati Uniti d'America 5.814
IE - Irlanda 494
SE - Svezia 492
PL - Polonia 482
IT - Italia 356
UA - Ucraina 226
CN - Cina 215
HK - Hong Kong 200
DE - Germania 171
FI - Finlandia 124
GB - Regno Unito 92
TR - Turchia 62
JO - Giordania 38
SG - Singapore 35
FR - Francia 26
KR - Corea 20
CA - Canada 18
SC - Seychelles 11
RU - Federazione Russa 10
BE - Belgio 8
VN - Vietnam 8
EU - Europa 5
NL - Olanda 5
ES - Italia 4
NZ - Nuova Zelanda 4
IN - India 2
TW - Taiwan 2
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
IL - Israele 1
LI - Liechtenstein 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
Totale 8.933
Città #
Fairfield 900
Chandler 619
Dublin 493
Warsaw 482
Woodbridge 425
Ashburn 393
Cambridge 392
Seattle 378
Jacksonville 374
Wilmington 327
Houston 304
Ann Arbor 161
Dearborn 156
Princeton 135
Altamura 121
Lawrence 121
Beijing 96
Boardman 96
Hong Kong 96
Medford 80
Boston 69
Buffalo 57
Izmir 56
San Diego 47
Florence 42
Norwalk 27
Kent 24
Shanghai 24
New York 22
Hefei 20
Seoul 19
Bremen 18
Singapore 18
Falls Church 15
Hillsboro 15
Auburn Hills 14
Los Angeles 13
Milan 13
Nanjing 11
Andover 10
Kunming 10
Toronto 10
Frankfurt Am Main 9
Jinan 9
London 9
Salerno 9
Verona 9
Brussels 8
Dong Ket 8
Guangzhou 7
Nanchang 6
Rockland 5
Fabriano 4
Fuzhou 4
Grezzana 4
Old Bridge 4
Hounslow 3
Phoenix 3
Prescot 3
Redwood City 3
Taiyuan 3
Albany 2
Ancona 2
Barcelona 2
Bari 2
Casorate Primo 2
Chengdu 2
Conegliano 2
Dallas 2
Islington 2
Kilburn 2
Lucca 2
Menlo Park 2
Mogliano Veneto 2
Moscow 2
Munich 2
Naaldwijk 2
Origgio 2
Padova 2
Porto Ercole 2
Rome 2
Seano 2
Stia 2
Taipei 2
Trento 2
Trumbull 2
Turin 2
Xian 2
Acri 1
Acton 1
Ameno 1
Auckland 1
Baotou 1
Bergamo 1
Birmingham 1
Brno 1
Cardiff 1
Castelfiorentino 1
Catania 1
Cerano 1
Totale 6.879
Nome #
Time perception impairment in early-to-moderate stages of Huntington's disease is related to memory deficits 228
Progression of brain atrophy in spinocerebellar ataxia type 2: A longitudinal tensor-based morphometry study 224
Huntington’s disease and Scalar Expectancy Theory: A memory-based time perception deficit 173
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 167
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 121
Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Italy 109
Association analysis of the paraoxonase-1 gene with Alzheimer's disease 109
IgM monoclonal gammopathy-associated neuropathies with different IgM specificity. 109
A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset. 105
Abnormalities of mitochondrial enzymes in hereditary ataxias. 105
Huntington disease: Volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain 103
ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias. 103
Lack of efficacy of phosphatidylcholine in ataxias. 100
A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia. 97
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. 97
No implication of apolipoprotein E polymorphism in Italian schizophrenic patients. 95
Fragile X premutation with atypical symptoms at onset. 95
Neurochirurgia riparativa: trapianto caudato-putaminale di tessuto striatale fetale umano nella malattia di Huntington. Progetto dell'Università di Firenze 94
Association of IL10 promoter polymorphism in Italian Alzheimer's disease. 94
Alterations in metabolic properties in fibroblasts in Alzheimer disease. 93
Molecular genetics of Alzheimer's disease in Italian families. 90
Insulin degrading enzyme and alpha-3 catenin polymorphisms in italian patients with Alzheimer disease 89
Abnormal platelet glutamate dehydrogenase activity and activation in dominant and nondominant olivopontocerebellar atrophy. 89
Alzheimer skin fibroblasts show increased susceptibility to free radicals. 89
Occurrence of transketolase abnormalities in extracts of foreskin fibroblasts from patients with Alzheimer's disease 87
Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies. 87
Free radical injury in skin cultured fibroblasts from Alzheimer's disease patients. 86
Double-blind, crossover, placebo-controlled clinical trial with L-acetylcarnitine in patients with degenerative cerebellar ataxia. 85
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. 85
Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease. 85
Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. 84
ApoE as a prognostic factor for post-traumatic coma. 84
ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. 83
Atypical Friedreich ataxia with a very late onset and an unusual limited GAA repeat. 83
Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities. 83
The first Alzheimer disease case: a metachromatic leukodystrophy? 82
ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families. 82
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion 82
Risperidone in idiopathic and symptomatic dystonia: preliminary experience. 81
Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. 81
No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy. 81
Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity 80
Lactate production and glycolytic enzymes in sporadic and familial Alzheimer’s disease. 80
DAPK1 is Associated with FTD and not with Alzheimer's Disease 80
Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. 80
Clinical and genetic characteristics of late-onset Huntington's disease 79
Suicidal ideation in a European Huntington's disease population 78
Neurodegeneration in Friedreich’s ataxia is associated with a mixed activation pattern of the brain. A fMRI study 77
Assessment of brain white matter fiber bundle atrophy in patients with Friedreich ataxia. 77
Long-term evolution of anti-ganglioside antibody levels in patient with chronic dysimmune neuropathy under IVIg therapy. 76
Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease 76
Genetics of Alzheimer's Disease and Frontotemporal Dementia 75
Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia 74
Effect of phosphatidylserine on free radical susceptibility in human diploid fibroblasts. 74
APP717 and Alzheimer's disease in Italy 73
Clinical and genetic analysis of hereditary and sporadic ataxia in central Italy. 72
Altered hexokinase activity in skin cultured fibroblasts and leukocytes from Alzheimer's disease patients 72
Absence of APP717 mutation in Italian FAD families 71
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 71
Trapianto di tessuto striatale fetale umano nella malattia di Huntington. Primi risultati del trial clinico italiano 71
Implication of sex and SORL1 variants in italian patients with Alzheimer disease. 70
Energy metabolism in demented brain. 70
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene 70
Combining functional and structural brain magnetic resonance imaging in Huntington disease. 69
Psychosis, serotonin receptor polymorphism and Alzheimer's disease 69
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder 69
Alzheimer's disease and apolipoprotein E in Italy. 68
Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. 68
Human fetal striatal transplantation in disease. First italian clinic trial at the University of Florence. Preliminare Report 67
Development of human striatal anlagen after transplantation in a patient with Huntington's disease. 67
Cystatin C and apoe polymorphisms in Italian Alzheimer'sdisease. 67
Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease. 66
PET study in subjects from two Italian FAD families with APP717 Val to Ileu mutation 66
Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease. 65
Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study. 65
Discrepancies in reporting the CAG repeat lengths for Huntington's disease 65
Brain structural damage in Friedreich's ataxia. 64
Molecular genetic strategies in familial Alzheimer's disease. Theoretical and practical considerations. 63
Trapianto intracerebrale di striato fetale nella malattia di Huntington: un aggiornamento dell'esperienza clinica italiana 63
Chemical lateralization in human temporal cortex. 62
Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease. 62
Normal lactate production and altered hexokinase activity in fibroblasts and leukocytes from familial Alzheimer's disease patients 62
The genetic defect causing familial Alzheimer's disease maps on chromosome 21 61
Use of phosphatidylserine in sporadic and familial Alzheimer's disease 61
Linkage Analysis in familial Alzheimer's disease 59
Kinetic studies of the mouse brain transketolase. 58
Protection from oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine 58
Deficiency of a specific diaphorase in Luft disease fibroblasts 55
Linkage Analysis in Italian Pedigrees with Autosomal Dominant Familial Alzheimer’s DiseaseCerebral Ischemia and Dementia 55
Implication of GAB2 Gene Polymorphism in Italian Patients with Alzheimer's Disease 54
Congenital ocular Myastenia: case report 53
ENZYMES OF ENERGY METABOLISM IN DEMENTED BRAIN 50
CO2-laser and electric somatosensory evoked potentials in Friedreich's ataxia. 49
Enzymes of energy metabolism in demented brain 49
Missense mutation of S182 gene in Italian families with early-onset Alzheimer's disease. 48
Gaze avoidance in subjects with extrapiramidal disorders 47
La malattia di Alzheimer 47
null 47
Genetic Analysis of familial and sporadic cases of spinocerebellar ataxias in Italian patients 47
Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer’s disease 47
Totale 8.037
Categoria #
all - tutte 24.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.962


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019786 0 0 0 0 0 0 0 0 0 0 441 345
2019/20202.259 175 149 52 185 218 325 342 286 204 135 155 33
2020/20211.103 116 66 108 92 22 165 26 111 100 144 67 86
2021/2022828 20 99 72 29 38 25 40 53 37 22 157 236
2022/20232.271 225 381 71 236 183 431 303 119 230 12 70 10
2023/2024664 48 102 129 44 63 55 33 133 3 9 45 0
Totale 8.987